We use cookies on our website, which are text files containing small amounts of information that are downloaded to your computer or mobile device. To find out more about the cookies we use please click here.

Some of these cookies are strictly necessary for operation of this site. Other, non-essential cookies are used for measuring website performance (which is all aggregated and anonymised) and may share this information with Google. To consent to non-essential cookies, click "Accept all non-essential cookies".

Dr Mark Wyatt

Investment Director


Mark is an Investment Director with over 18 years' venture capital experience, with particular expertise in the life science sector. He has been involved in all aspects of creating venture backed businesses, including sourcing new opportunities, working with founders and management teams to build valuable propositions, through to public market listings and trade sales. He has been a non-executive director of several private and public companies. Mark works across several early-stage venture funds, including the RisingStars Growth Funds, the North West Fund for Venture Capital, Finance Yorkshire Seedcorm Fund, and is actively looking for new life science deals for the Northern Powerhouse Fund.

Previous experience

Mark spent two years as bioscience ventures manager at London-based Imperial Innovations. Prior to joining Imperial, Mark had spent the previous five years with Mercia’s Technology team based in the North West, and before that, six years at Merlin Biosciences, a venture capital and advisory company dedicated to the life sciences sector.

© Mercia Technologies 2019

Terms and conditions Privacy policy

Designed and built by Onespacemedia